SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in Emeryville, CA.

Novabay Pharmaceuticals Inc

Novabay Pharmaceuticals is trending due to a recently announced special cash dividend of $0.80 per share and an anticipated strategic pivot towards emerging financial infrastructure and blockchain-based assets under new leadership. This has ignited robust community debate around the stock's 'monster runner' potential and short-squeeze dynamics, balancing speculative growth opportunities against concerns of significant dilution. Traders are actively navigating this heightened volatility, watching how this biotech-to-blockchain shift performs amid current small-cap market enthusiasm.

Starfighters Space Inc

Starfighters Space Inc. (FJET) is a trending, highly volatile new IPO in the space sector, generating significant community debate around its unique commercial supersonic fleet and payload launch capabilities. While some investors are bullish on its potential as a 'space pure-play' amidst broader industry interest, others express strong skepticism, citing concerns about warrants, dilution, and a lack of detailed operational transparency as the stock experiences notable price swings.

AGCO Corp. engages in the manufacture and distribution of agricultural equipment and related replacement parts. It operates through the following geographic segments: North America, South America, Europe and Middle East, and Asia, Pacific, and Africa. The Asia/Pacific/Africa segment includes the regions of Australia and New Zealand. The firm's products include tractors, combines, self-propelled sprayers, hay tools, forage equipment, seeding and tillage equipment, implements, and grain storage and protein production systems. Its brands include Challenger, Fendt, GSI, Massey Ferguson, Valtra, and Fella. The company was founded by Robert J. Ratliff in 1990 and is headquartered in Duluth, GA.

AGCO Corp.

AGCO is trending after its recent Q2 earnings missed estimates and the company lowered its full-year outlook, citing weakening agricultural industry demand. This has fueled significant investor discussion and frustration, despite AGCO's strategic shift towards high-margin precision agriculture with the PTx Trimble joint venture and the divestiture of its Grain & Protein business. The market is weighing these long-term strategic benefits against immediate operational challenges and a recently announced restructuring program.

Newmont Corp. engages in the exploration and acquisition of gold properties, containing copper, silver, lead, zinc or other metals. It operates through the following geographical segments: Canada, Mexico, Suriname, Argentina, Peru, Australia, Papua New Guinea, Ghana, and U.S. The company was founded by William Boyce Thompson on May 2, 1921 and is headquartered in Denver, CO.

Newmont Corp

Newmont Corp. is a central talking point following its latest earnings report, which, despite beating expectations amid elevated gold prices, saw a stock pullback, fueling community debate about market dynamics versus conservative guidance. Many investors are seizing the opportunity to accumulate shares, bullish on Newmont's long-term potential as a leading gold miner positioned to benefit from sustained high gold prices and broader economic uncertainties.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is experiencing a massive surge following an $816 million prime contract from the Space Development Agency to build 18 missile defense satellites, cementing its role as a key player in national security space. The community is buzzing with bullish sentiment, anticipating further contract wins and a significant re-rating of the stock's valuation, especially given upcoming catalysts and comparisons to the broader space sector.

Avantis is the largest RWA perps DEX in DeFi, built on and backed by Base. Avantis allows users to trade crypto and real-world assets (RWAs), including FX, commodities, indices, and equities. Backed by Pantera and Coinbase, Avantis is the largest DEX on Base by volumes, and brings institutional-grade products to DeFi, letting users trade with up to 500x leverage in a transparent, permissionless environment.  Avantis is best known for launching zero-fee perpetuals (ZFP) — a first-of-its-kind primitive where traders only pay fees if they profit. They've also brought leveraged RWAs onchain. This has driven explosive growth: over $20B+ in cumulative volume and 15M+ run-rate revenues since Febrruary 2024.

Avantis

Avantis (AVNT CRYPTO) is trending due to its pivotal role as a perpetual decentralized exchange integrated with Coinbase's Base network, offering high-leverage trading and real-world assets. The community is sharply divided, with strong optimism about its features and recent Robinhood listing countered by significant frustration regarding its price trajectory, alleged token unlocks, and comparisons to competitors like ASTER on BNB.

Verizon Communications, Inc. is a holding company, which engages in the provision of communications, information, and entertainment products and services. It operates through the Consumer and Business segments. The Consumer segment provides consumer-focused wireless and wire line communications services and products. The Business segment offers wireless and wireline communications services and products, including FWA broadband, data, video and conferencing services, corporate networking solutions, security and managed network services, local and long-distance voice services, and network access to deliver various IoT services and products. The company was founded in 1983 and is headquartered in New York, NY.

Verizon Communications Inc

Verizon Communications Inc.

Verizon is trending as its new CEO implements a significant restructuring, including substantial job reductions, aiming to boost margins while reiterating a firm commitment to the dividend. The community is keenly observing how these aggressive cost-cutting measures and strategic infrastructure investments will position the telecom giant against fierce competition from both traditional rivals and emerging satellite internet services.

Airbnb, Inc. engages in the management and operation of an online marketplace. Its marketplace model connects hosts and guests online or through mobile devices to book spaces. The company was founded by Brian Chesky, Nathan Blecharczyk and Joseph Gebbia in 2007 and is headquartered in San Francisco, CA.

Airbnb Inc - Ordinary Shares - Class A

Airbnb Inc

Airbnb is trending following recent analyst upgrades, most notably RBC Capital raising its rating to Outperform and increasing its price target. The community is actively discussing the company's long-term growth potential through initiatives like AI-powered party prevention and a broader push into the travel ecosystem, including hotels. While some investors highlight the ongoing travel boom and strong fundamentals, others remain cautious regarding its historical price performance and market competition.

Ancient8 is the gaming L2 on Ethereum backed by Dragonfly, Pantera, Hashed, Coinbase Ventures and Makers Fund. Ancient8 offers a suite of Web3 gaming infrastructure tools that serve as the distribution and marketing channel for games globally.

Ancient8

A8 CRYPTO is a trending topic, primarily due to its status as a recently listed gaming token, igniting a highly polarized debate within the community. Many bulls are anticipating a significant 'alt season' rally, drawing comparisons to other tokens that experienced substantial post-listing pumps, while a vocal skeptical faction labels it a 'scam' or 'rugpull' due to concerns over token distribution and developer practices.

Tidal Trust II - Defiance Daily Target 2x Long SMCI ETF

Defiance Daily Target 2X Long SMCI ETF

SMCX is trending due to significant volatility in its underlying asset, Super Micro Computer (SMCI), a crucial player in AI server infrastructure, driving intense 'buy the dip' activity among many investors. The community is highly engaged in discussions about the optimal entry points, balancing the potential for amplified gains from this 2x leveraged ETF against its inherent decay and dramatic price swings. Despite cautionary tales and recent downturns, a strong underlying bullish sentiment anticipates a substantial rebound fueled by future growth in the AI sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Quince Therapeutics Announces Last Patient Last Visit in Phase 3 NEAT Clinical Trial in Patients with Ataxia-Telangiectasia

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patients own biology for the treatment of rare diseases, today announced that the...

Quince Therapeutics Announces Publication of Use of eDSP in Early-Stage Clinical Studies in Pulmonary and Inflammatory Bowel Disorders

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patients own biology for the treatment of rare diseases, announced the publication...

Monday Sector Laggards: Biotechnology, Electronic Equipment & Products

In trading on Monday, biotechnology shares were relative laggards, down on the day by about 3%. Helping drag down the group were shares of Quince Therapeutics, down about 16.2% and shares of Kalaris...

169,554 Shares in Quince Therapeutics, Inc. $QNCX Bought by Rockefeller Capital Management L.P.

Rockefeller Capital Management L.P. purchased a new stake in Quince Therapeutics, Inc. (NASDAQ:QNCX - Free Report) in the second quarter, according to its most recent Form 13F filing with the...

Quince Therapeutics to Participate at Investor Events in December 2025

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patients own biology for the treatment of rare diseases, today announced that senior...

Brookline Capital Management Predicts QNCX FY2028 Earnings

Quince Therapeutics, Inc. (NASDAQ:QNCX - Free Report) - Brookline Capital Management cut their FY2028 earnings estimates for shares of Quince Therapeutics in a report released on Thursday, November...

D. Boral Capital Reiterates "Buy" Rating for Quince Therapeutics (NASDAQ:QNCX)

D. Boral Capital reissued a "buy" rating and issued a $4.00 price target on shares of Quince Therapeutics in a research note on Thursday...

Quince Therapeutics (NASDAQ:QNCX) Announces Quarterly Earnings Results

Quince Therapeutics (NASDAQ:QNCX - Get Free Report) released its quarterly earnings data on Wednesday. The company reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus...

Quince Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patients own biology for the treatment of rare diseases, today provided an update on...

Quince Therapeutics Announces Positive iDSMB Review for eDSP in Pivotal Phase 3 NEAT Clinical Trial in Ataxia-Telangiectasia

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patients own biology for the treatment of rare diseases, today announced the...

Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in the unlocking the power of a patient’s biology for the treatment of rare diseases. Its product includes EryDex, developed using their proprietary Autologous Intracellular Drug Encapsulation (AIDE) technology platform, which is a novel device combination that uses an automated process designed to encapsulate a drug into the patient’s own red blood cells. The company was founded by Casey Crawford Lynch, Stephen Dominy, and Kristen Gafric on June 20, 2012 and is headquartered in South San Francisco, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.18	--	--	N/A
Q3 '25	-$0.22	-$0.25	-16.28%	MISSED
Q2 '25	-$0.25	-$0.34	-35.10%	MISSED
Q1 '25	-$0.23	-$0.34	-49.45%	MISSED
Q4 '24	-$0.16	-$0.19	-21.28%	MISSED

QNCX
Quince Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest QNCX News

QNCXQuince Therapeutics Inc